These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3719574)

  • 21. Dystonia in multiple system atrophy.
    Boesch SM; Wenning GK; Ransmayr G; Poewe W
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):300-3. PubMed ID: 11861684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical heterogeneity of dopa-responsive dystonia: PET observations.
    Takahashi H; Snow BJ; Nygaard TG; Calne DB
    Adv Neurol; 1993; 60():586-90. PubMed ID: 8420195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
    Hanakawa T; Fukuyama H; Akiguchi I; Kato M; Kimura J; Shibasaki H
    Rinsho Shinkeigaku; 1996 May; 36(5):655-60. PubMed ID: 8905984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
    McHale DM; Sage JI; Sonsalla PK; Vitagliano D
    Clin Neuropharmacol; 1990 Apr; 13(2):164-70. PubMed ID: 2328507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
    Snow BJ; Nygaard TG; Takahashi H; Calne DB
    Ann Neurol; 1993 Nov; 34(5):733-8. PubMed ID: 8239569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DOPA-responsive dystonic parkinsonism--pathophysiologic considerations.
    Segawa M; Nishiyama N; Nomura Y
    Adv Neurol; 1999; 80():389-400. PubMed ID: 10410746
    [No Abstract]   [Full Text] [Related]  

  • 28. [Parkinson's Disease with Intolerable Painful Dystonia: Classification and Therapeutic Choices of Pain in Parkinson' Disease].
    Kajiyama Y; Mochizuki H
    Brain Nerve; 2022 May; 74(5):462-467. PubMed ID: 35589632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of dystonia in atypical parkinsonism.
    Godeiro-Junior C; Felício AC; Barsottini OG; Aguiar PM; Silva SM; Borges V; Ferraz HB
    Arq Neuropsiquiatr; 2008 Dec; 66(4):800-4. PubMed ID: 19099114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from a remarkable family with dopa-responsive dystonia.
    Harwood G; Hierons R; Fletcher NA; Marsden CD
    J Neurol Neurosurg Psychiatry; 1994 Apr; 57(4):460-3. PubMed ID: 8163996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Open label evaluation of cannabidiol in dystonic movement disorders.
    Consroe P; Sandyk R; Snider SR
    Int J Neurosci; 1986 Nov; 30(4):277-82. PubMed ID: 3793381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family.
    Nygaard TG; Trugman JM; de Yebenes JG; Fahn S
    Neurology; 1990 Jan; 40(1):66-9. PubMed ID: 2296384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the role of spinal cord systems in Parkinson's disease-associated pain.
    Sage JI; Kortis HI; Sommer W
    Clin Neuropharmacol; 1990 Apr; 13(2):171-4. PubMed ID: 2328508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
    Pouclet H; Derkinderen P; Lebouvier T
    Clin Neurol Neurosurg; 2013 Feb; 115(2):235-6. PubMed ID: 22743235
    [No Abstract]   [Full Text] [Related]  

  • 35. Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology.
    Poewe W; Lees AJ; Steiger D; Stern GM
    Adv Neurol; 1987; 45():357-60. PubMed ID: 3825711
    [No Abstract]   [Full Text] [Related]  

  • 36. Dystonia in Parkinson's disease.
    Tolosa E; Compta Y
    J Neurol; 2006 Dec; 253 Suppl 7():VII7-13. PubMed ID: 17131231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations.
    de la Fuente-Fernández R
    Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia.
    Virmani T; Thenganatt MA; Goldman JS; Kubisch C; Greene PE; Alcalay RN
    Parkinsonism Relat Disord; 2014 Feb; 20(2):245-7. PubMed ID: 24182522
    [No Abstract]   [Full Text] [Related]  

  • 39. CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
    Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H
    Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192
    [No Abstract]   [Full Text] [Related]  

  • 40. [A family of parkinsonism in which the clinical feature of constituents varied with the age of onset].
    Sasaki R; Kuzuhara S; Taniguchi A; Narita Y; Naito Y
    Rinsho Shinkeigaku; 1994 Jul; 34(7):736-8. PubMed ID: 7955737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.